These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37016445)

  • 1. Responsiveness of Persian 12-Item multiple sclerosis walking scale: a replication study.
    Naghdi S; Ansari NN; Haghparast A; Nakhostin-Ansari A; Khalifeloo M; Biglar M; Lotfi R; Hasson S
    BMC Res Notes; 2023 Apr; 16(1):45. PubMed ID: 37016445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness and clinically meaningful changes for the Persian versions of the multiple sclerosis walking scale-12 and the modified fatigue impact scale following balance and gait rehabilitation in people with multiple sclerosis.
    Monjezi S; Molhemi F; Shaterzadeh Yazdi MJ; Salehi R; Mehravar M; Kashipazha D
    Physiother Theory Pract; 2022 Mar; 38(3):464-470. PubMed ID: 32431220
    [No Abstract]   [Full Text] [Related]  

  • 3. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis Walking Scale-12, translation, adaptation and validation for the Persian language population.
    Nakhostin Ansari N; Naghdi S; Mohammadi R; Hasson S
    Gait Posture; 2015 Feb; 41(2):420-4. PubMed ID: 25444584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and longitudinal validity of the Persian version of COMI to physiotherapy in patients with non-specific chronic low back pain.
    Komesh S; Nakhostin Ansari N; Naghdi S; Alaei P; Hasson S; Kordi R
    Scand J Pain; 2020 Jul; 20(3):483-490. PubMed ID: 32101531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
    Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
    Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
    Engelhard MM; Schmidt KM; Engel CE; Brenton JN; Patek SD; Goldman MD
    Qual Life Res; 2016 Dec; 25(12):3221-3230. PubMed ID: 27342237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P
    Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of the Croatian version of the Multiple Sclerosis Walking Scale (MSWS-12).
    Jerković A; Nikolić Ivanišević M; Šimić N; Poljičanin A; Đogaš Z; Rogić Vidaković M
    Disabil Rehabil; 2023 Oct; 45(20):3373-3378. PubMed ID: 36222552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW; Plummer P; Backus D; Hebert JR; Neal WN; Ng A; Lowman J; Bethoux F; Schmidt H; McBurney R; McCully KK; Cutter G
    Mult Scler Relat Disord; 2024 Aug; 88():105715. PubMed ID: 38889558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the 4-meter walk test in patients with multiple sclerosis.
    Ozkan T; Unluer NO; Ates-Sari Y; Hangun SF; Vural G
    Mult Scler Relat Disord; 2024 Jul; 87():105679. PubMed ID: 38759422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis.
    Cohen JA; Krishnan AV; Goodman AD; Potts J; Wang P; Havrdova E; Polman C; Rudick RA
    JAMA Neurol; 2014 Nov; 71(11):1386-93. PubMed ID: 25178496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
    J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
    Binshalan T; Buckley E; Nair S; Mcneill A
    Cureus; 2024 Jan; 16(1):e51811. PubMed ID: 38322083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of two Persian-versions of shoulder outcome measures following physiotherapy intervention in patients with shoulder disorders.
    Negahban H; Behtash Z; Sohani SM; Salehi R
    Disabil Rehabil; 2015; 37(24):2300-4. PubMed ID: 25640004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting faller status in persons with multiple sclerosis using the Multiple Sclerosis Walking Scale-12.
    Abate C; Gromisch ES; Campo M; Ruiz JA; DelMastro HM
    Mult Scler Relat Disord; 2024 Dec; 92():105924. PubMed ID: 39406155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.
    Goldman MD; Ward MD; Motl RW; Jones DE; Pula JH; Cadavid D
    Mult Scler; 2017 Sep; 23(10):1405-1414. PubMed ID: 27903937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.